Marinomed(奧地利)

Marinomed

Marinomed www.marinomed.comMarinomedBiotechnologieGmbH創(chuàng)立于2006年，在一個(gè)創(chuàng)新的抗病毒呼吸技術(shù)平臺(tái)基礎(chǔ)上開(kāi)發(fā)呼吸系統(tǒng)疾病的治療藥物。該技術(shù)的上市產(chǎn)品是一種抗病毒鼻腔噴霧劑，已證明該技術(shù)安全有效，具有實(shí)用性。Marinomed在流感、抗哮喘藥合劑和其他高危患者方面也有進(jìn)一步的專攻產(chǎn)品，體現(xiàn)出該技術(shù)的巨大潛力。此外，該公司還開(kāi)發(fā)一種針對(duì)I型變態(tài) 反應(yīng)和自身免疫疾病的新藥。MarinomedBiotechnologieGmbH是從維也納獸醫(yī)大學(xué)分拆出來(lái)的公司，總部在奧地利維也納。 Marinomedisabiopharmaceuticalcompanydiscoveringanddevelopinginnovativeanti-viralandimmunologicaltreatments.MarinomedhasdevoteditsdiscoveryandresearcheffortstotheevolutionofMAVIREX,atechnologyplatformforthedevelopmentoftherapiesthattargetmorethan200differentrespiratoryvirusstrainsbasedonpolymersderivedfromredseaweed.ThehugepotentialofthistechnologyisreflectedbyCarragelose©,auniquebroadlyactiveanti-viralcompoundfortreatingrespiratorydiseases.Safetyandantiviraleffectivenesshavebeenestablishedinclinicaltrialsinvolvingbothadultsandchildren.Thecompoundisapprovedformarketinginthe